Lipinski et al. evaluated PSs, liver cirrhosis, and spleen size using US in 982 patients with liver cirrhosis, and correlated these with laboratory results, clinical data, and the incidence of clinical endpoint deaths, liver transplantation, and the development of hepatocellular carcinoma (HCC) during the follow-up periods (mean 1.26 ± 1.53 ....